SHR2554
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for SHR2554, covering 2023-12-12 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer [Phase 2]